Accelerate Diagnostics reported -17590000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2545M 1153M
Becton, Dickinson and BDX:US $ 495M 133M
Bio Rad Laboratories BIO:US $ 156.8M 32.02M
Bruker BRKR:US $ 113.2M 27.6M
Danaher DHR:US $ 1309M 696M
Exact Sciences EXAS:US $ -162.02M 9.64M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Hologic HOLX:US $ 439.5M 80.9M
Illumina ILMN:US $ -545000000 732M
Luminex LMNX:US $ 13.46M 2.96M
Meridian Bioscience VIVO:US $ 8.49M 7.19M
Myriad Genetics MYGN:US $ -79.9M 59.1M
Nanostring Technologies NSTG:US $ -29.37M 3.74M
Oxford Immunotec Global OXFD:US $ 0.28M 10.11M
Pacific Biosciences Of California PACB:US $ -74.48M 36.9M
Perkinelmer PKI:US $ 221.97M 110.52M
Quidel QDEL:US $ 281.84M 258.54M
Thermo Fisher Scientific TMO:US $ 2278M 115M